Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer

Reviews of Infectious Diseases

Volumn 12, Issue 6, 1990, Pages 997-1003

  Khardori, Nancy ^a   Elting, Linda ^a   Wong, Edna ^a   Schable, Barbara ^a   Bodey, Gerald P ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFAMANDOLE; CEFSULODIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; IMIPENEM; LATAMOXEF; MEZLOCILLIN; PIPERACILLIN; POLYMYXIN B; SULFAMETHOXAZOLE; TICARCILLIN; TIMENTIN; TOBRAMYCIN; TRIMETHOPRIM;

ARTICLE; CANCER; DISEASE TRANSMISSION; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; XANTHOMONAS;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; EQUIPMENT CONTAMINATION; FEMALE; HUMAN; LEUKEMIA; MALE; MIDDLE AGE; NEOPLASMS; NEUTROPENIA; PNEUMONIA; SEPTICEMIA; WATER MICROBIOLOGY; XANTHOMONAS;

EID: 0025221435     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.6.997     Document Type: Article

References (28)

1. Hugh R, Ryschenkow E. An alcaligenes-like pseudomonas species [abstract no. 690]. Bacteriological Proceedings 1960;60:78
2. Stanier RY, Palleroni NJ, Doudoroff M. The aerobic pseudomonads: a taxonomic study. J Oen Microbiol 1966; 43:159–271
3. Gilardi GL. Pseudomonas maltophilia infections in man. Am J Clin Pathol 1969;51:58–61
4. Harlowe HD. Acute mastoiditis following Pseudomonas maltophilia infection: case report. Laryngoscope 1972;82:882–3
5. Sutter VL. Identification of Pseudomonas species isolated from hospital environment and human sources. Appl Environ Microbiol 1968;16:1532–8
6. Ben-Tovim T, Eylan E, Romano A, Stein R. Gram-negative bacteria isolated from external eye infections. Infection 1974;2:162–5
7. Gardner P, Griffin WB, Swartz MN, Kunz LJ. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med 1970;48:735–49
8. Sonnenwirth AC. Bacteremia with and without meningitis due to Yersinia enterocolitica, Edwardsiella tarda, Comamonas terrigena, and Pseudomonas maltophilia. Ann NY Acad Sci 1970;174:488–502
9. Yu VL, Rumans LW, Wing EJ, McLeod R, Sattler FN, Harvey RM, Deresinski SC. Pseudomonas maltophilia causing heroin-associated infective endocarditis. Arch Intern Med 1978;138:1667–71
10. Bassett DC, Stokes KJ, Thomas WR. Wound infection with Pseudomonas multivorans. A water-borne contaminant of disinfectant solutions. Lancet 1970;1:1188–91
11. Dailey RH, Benner EJ. Necrotizing pneumonitis due to the pseudomonas “eugonic oxidizer-group I”. N Engl J Med 1968;279:361–2
12. Ederer GM, Matsen JM. Colonization and infection with Pseudomonas cepacia. J Infect Dis 1972;125:613–8
13. Gilardi GL. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med 1972;77:211–5
14. Neu HC, Garvey GJ, Beach MP. Successful treatment of Pseudomonas cepacia endocarditis in a heroin addict with trimethoprim-sulfamethoxazole. J Infect Dis 1973;128 (Suppl):768–70
15. Schable B, Rhoden DL, Hugh R, Weaver RE, Khardori N, Smith PB, Bodey GP, Anderson RL. Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens. J Clin Microbiol 1989;27:1011–4
16. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Publ. no. M7-A. Villanova, Pa: National Committee for Clinical Laboratory Standards, 1985
17. Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990;11:134–8
18. Holmes B, Lapage SP, Easterling BG. Distribution in clinical material and identification of Pseudomonas maltophilia. J Clin Pathol 1979;32:66–72
19. Zuravleff JJ, Yu VL. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis 1982;4:1236–46
20. Maki DG. Nosocomial bacteremia: an epidemiologic overview. Am J Med 1981;70:719–32
21. Moffett HL, Allan D, Williams T. Survival and dissemination of bacteria in nebulizers and incubators. Am J Dis Child 1967;114:13–20
22. Moffett HL, Williams T. Bacteria recovered from distilled water and inhalation therapy equipment. Am J Dis Child 1967;114:7–12
23. Moody MR, Young VM, Kenton DM. In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother 1972;2:344–9
24. Moody MR, Young VM. In vitro susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 1975;7:836–9
25. Tilton RC, Steingrimsson O, Ryan RW. Susceptibilities of Pseudomonas species to tetracycline; minocycline, gentamicin, and tobramycin. Am J Clin Pathol 1978;69:410–3
26. Garau J, Martin R, Bouza E, Romero J, Rodriguez J.A.G., Perea E, Luengas FM, Gobernado M, Montero R. Imipe- nem in the treatment of severe bacterial infections in seriously ill patients. J Antimicrob Chemother 1986;18(Suppl E):131–40
27. Calandra GB, Brown KR, Grad LC, Ahonkhai VI, Wang C, Aziz MA. Review of adverse experiences and tolerability in the first 2516 patients treated with imipenem/cilastatin. Am J Med 1985;78(Suppl 6A):73–8
28. Felegie TP, Yu VL, Rumans LW, Yee RB. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 1979;16:833–7